Garrett Ingram
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Garrett Ingram
Earlier roles on record: Board Member at Avenue Therapeutics, Inc. (ATXI) until October 31, 2022. Avenue Therapeutics, Inc. reported in an 8-K filed November 4, 2022 that Garrett Ingram resigned as member of the Board and all committees thereof, effective October 31, 2022.
“On October 31, 2022, and in connection with the closing of the repurchase of the InvaGen Shares and satisfaction of certain additional obligations in the Share Repurchase Agreement, each of Jaideep Gogtay, M.D. and E. Garrett Ingram, the two non-independent members of the Board originally selected by InvaGen, resigned as members of the Board and all committees thereof, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2019-01-01–2022-10-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.